<DOC>
	<DOCNO>NCT00903474</DOCNO>
	<brief_summary>RATIONALE : Mindful movement self-directed activity mindfulness ( intention , attention , attitude ) physical movement . A mindful movement program may effective improve well-being old woman breast cancer survivor . PURPOSE : This randomized clinical trial study well mindful movement program work improve quality life old female breast cancer survivor .</brief_summary>
	<brief_title>Mindful Movement Program Improving Quality Life Older Female Breast Cancer Survivors</brief_title>
	<detailed_description>OBJECTIVES : - To test effect 12-week Mindful Movement Program quality life old female breast cancer survivor . - To test effect program mindfulness outcomes participant . - To compare mindfulness quality experimental group control group . - To determine qualitative benefit program describe participant . OUTLINE : Participants randomize 1 2 intervention arm . - Arm I ( Mindful Movement Program [ MMP ] ) : Participants undergo 2-hour MMP session weekly 12 week . Participants encourage practice intentional-mindful movement home 5 minute daily week 1-4 , 10 minute daily week 5-8 , 15 minute daily week 9-12 . Mindful movement self-directed activity incorporate mindfulness concept physical movement . Mindfulness consist three core element : intention ( reason participate mindfulness intervention ) , attention ( observe experience present moment ) , attitude ( nonjudgmental openness acceptance experience ) . Each MMP session include verbal share partner group movement individually partner , focus element mindfulness . Music incorporated portion session . - Arm II ( control ) : Participants undergo intervention . All participant complete questionnaire sociodemographic individual characteristic , quality life ( include psychological , social , spiritual , physical well-being , anxiety depression , fear recurrence , body image , upper body symptom ) , movement , mindfulness ( include attention , self-compassion , intention ) baseline week 12 18 . PROJECTED ACCRUAL : A total 75 participant ( 45 experimental group 30 control group ) accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Breast cancer survivor At least 12 month since completion treatment ( chemotherapy , biotherapy [ e.g. , trastuzumab ] , radiotherapy ) No evidence metastatic disease PATIENT CHARACTERISTICS : English speaking Not acute psychological distress Not use assistive device ( cane , walker , wheelchair ) Able participate Mindful Movement Program medical release patient 's physician Pregnancy allow PRIOR CONCURRENT THERAPY : See Disease Characteristics Concurrent selective estrogenreceptor modulator permit No concurrent treatment</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>anxiety disorder</keyword>
	<keyword>depression</keyword>
	<keyword>cognitive/functional effect</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>cancer survivor</keyword>
	<keyword>breast cancer</keyword>
</DOC>